Shares of Merck experienced a significant drop following a surprising sales forecast for 2025, influenced by a temporary halt ...

This update provides insights into critical global health developments, including Merck's halt on Gardasil shipments to China ...

Vamil Divan, Guggenheim Securities biopharmaceutical analyst, joins 'Power Lunch' to discuss Merck's troubles in China.

CNN’s Ben Wedeman dives deep underground in Rome to explore the Aqua Virgo, an ancient aqueduct that continues to supply ...

A Kennewick women's clinic is opening a new location for women's healthcare and aesthetic treatment in Yakima.

A global pharmaceutical company partnered with DelveInsight to create a robust and simplified solution enabling its top ...

Among active stocks, Estée Lauder ( EL) is the weakest stock in the S&P after the company’s downbeat outlook into the current fiscal quarter, along with plans to revive the business through job cuts ...

Merck has a positive record of earnings surprises ... enhancing reach to 8,000 retail locations and driving economies of scale, operational synergies, and revenue diversification.

Today's Research Daily features a real-time update on the Q4 earnings season and fresh Chevron (CVX), Merck (MRK), QUALCOMM (QCOM), as well as two micro-cap stocks CSP Inc. (CSPI) and AMCON ...

Merck Senior Vice President of Manufacturing Dave Maraldo said ... More than 105,000 students study at Purdue across modalities and locations, including nearly 50,000 in person on the West Lafayette ...

Merck is ending a Phase 3 trial of Winrevair early so all PAH patients in HYPERION can start active treatment with the drug ...

DJIA stocks to watch today. Market trends show gains in retail, tech, and energy. Get insights on Walmart, Apple, Amazon, and more!